Suppr超能文献

基于植入物的乳房再造术(使用与不使用脱细胞真皮基质)的经济分析和文献回顾。

Economic analysis and review of the literature on implant-based breast reconstruction with and without the use of the acellular dermal matrix.

机构信息

Department of Surgery, Section of Plastic and Reconstructive Surgery, University of Chicago Medical Center, 5841 South Maryland Avenue, Chicago, IL, 60637, USA.

出版信息

Aesthetic Plast Surg. 2013 Dec;37(6):1194-201. doi: 10.1007/s00266-013-0213-2. Epub 2013 Oct 3.

Abstract

BACKGROUND

Use of the acellular dermal matrix (ADM) in two-stage implant-based breast reconstruction has been widely adopted. Despite an increasing focus on health care costs, few reports have addressed the financial implications of ADM use. This study sought to examine the costs of the two-stage technique with and without ADM, concentrating on the direct variable costs of patient care during the expansion process.

METHODS

A retrospective review of a prospectively maintained database was conducted. Data were collected on 132 cases resulting in a second-stage exchange for a permanent implant. The findings showed that AlloDerm was used in 61 reconstructions and Strattice in 23 reconstructions. The primary outcome was the number of fills required to achieve the final expander fill volume. The cost of subsequent patient encounters for expansion was estimated using institutional cost data.

RESULTS

The number of fills required to achieve the final volume was higher in the non-ADM group (6.5 ± 1.7) than in the ADM group (3.6 ± 1.4) (p < 0.0001). No significant difference was found in the small fill volumes (<350 ml; 5.3 vs. 3.7; p > 0.05). The difference was significant in the larger fill volumes (>500 ml; 8.3 vs. 3.7; p < 0.05). Relative to non-ADM reconstruction, with AlloDerm at current prices, the cost increase ranged from $2,727.75 for large reconstructions to $3,290.25 for small reconstructions ($2,167.75-$2,739.25 with Strattice).

CONCLUSION

The use of ADM in two-stage reconstruction reduces the number of visits required for reconstructions with 350 ml or more. However, at current pricings, the direct cost of ADM use does not offset the cost savings from the reduced number of visits.

LEVEL OF EVIDENCE IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

摘要

背景

脱细胞真皮基质(ADM)在两阶段基于植入物的乳房重建中的应用已被广泛采用。尽管越来越关注医疗保健成本,但很少有报告涉及 ADM 使用的财务影响。本研究旨在检查使用和不使用 ADM 的两阶段技术的成本,重点关注扩展过程中患者护理的直接变量成本。

方法

对前瞻性维护的数据库进行回顾性审查。共收集了 132 例因永久性植入物而进行第二期手术的病例数据。结果显示,61 例重建使用了 AlloDerm,23 例重建使用了 Strattice。主要结果是达到最终扩张器填充体积所需的填充次数。使用机构成本数据估计了后续扩张患者就诊的费用。

结果

非 ADM 组(6.5±1.7)达到最终体积所需的填充次数高于 ADM 组(3.6±1.4)(p<0.0001)。在小填充量(<350ml;5.3 与 3.7;p>0.05)之间未发现显著差异。在较大的填充量(>500ml;8.3 与 3.7;p<0.05)之间存在显著差异。与非 ADM 重建相比,使用当前价格的 AlloDerm,成本增加范围从大重建的 2727.75 美元到小重建的 3290.25 美元(Strattice 为 2167.75-2739.25 美元)。

结论

在两阶段重建中使用 ADM 可减少 350ml 或更多重建所需的就诊次数。然而,以当前价格计算,ADM 使用的直接成本并不能抵消就诊次数减少带来的成本节约。

证据水平 IV:本杂志要求作者为每篇文章分配一个证据水平。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南 www.springer.com/00266

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验